Succinamic acid ethyl ester
CAS: 53171-35-0
Ref. 3D-DCA17135
| 1g | To inquire | ||
| 5g | To inquire | ||
| 10g | To inquire | ||
| 250mg | To inquire | ||
| 500mg | To inquire |
Product Information
- Butanoic acid, 4-amino-4-oxo-, ethyl ester
Succinamic acid ethyl ester is a matrix metalloproteinase inhibitor that inhibits the activity of matrix metalloproteinases, which are enzymes that break down the extracellular matrix. Succinamic acid ethyl ester has been shown to inhibit type IV collagenase and gelatinase, two of the most important enzymes involved in tissue remodeling. This agent may be useful for the treatment of inflammatory diseases, cancer, and autoimmune diseases. Succinamic acid ethyl ester also acts as a modulator of insulin resistance and may be used to treat diabetes mellitus. Succinamic acid ethyl ester binds to an amide-binding site on the receptor binding domain of insulin receptor with high affinity. It also inhibits pro-inflammatory cytokines such as tumor necrosis factor-α (TNF-α) and IL-1β.
Chemical properties
Technical inquiry about: 3D-DCA17135 Succinamic acid ethyl ester
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
